Alcohol-Related Liver Disease (ARLD) is a leading cause of chronic liver disease worldwide, ranging from fatty liver and alcoholic hepatitis to cirrhosis and hepatocellular carcinoma. As part of the Global Gastroenterology, Liver Diseases & Hepatology Conference & Industry Expo, this focused session addresses the growing global burden of alcohol-associated liver injury and the urgent need for innovative, multidisciplinary solutions.
The ARLD program will showcase advances in early diagnosis, risk stratification, biomarkers, medical and interventional therapies, transplantation, and supportive care. Experts will discuss the role of lifestyle modification, addiction medicine, public health strategies, and precision hepatology in improving patient outcomes.
This platform also emphasizes innovation, investment, and industry partnerships, connecting clinicians, researchers, pharmaceutical and biotech leaders, digital health innovators, and policymakers. Through scientific sessions, industry showcases, and collaborative discussions, participants will explore translational research, novel therapeutics, regulatory pathways, and commercialization opportunities.
Join global leaders to shape the future of ARLD management through science-driven innovation, strategic investment, and impactful industry collaboration.
Sub Topics: Epidemiology of Alcohol-Related Liver Disease, Global burden and trends of ARLD, Alcohol metabolism and liver injury mechanisms, Genetic susceptibility in ARLD, Gut-liver axis and alcohol-induced dysbiosis, Alcohol-associated fatty liver disease, Pathophysiology of alcoholic hepatitis, Biomarkers for early ARLD detection, Non-invasive diagnostic tools in ARLD, Imaging advances in alcohol-related liver disease, Role of inflammation in ARLD progression, Immune dysfunction in alcoholic liver disease, Oxidative stress and liver injury, Fibrosis and cirrhosis in chronic alcohol use, Acute-on-chronic liver failure in ARLD, Management of alcoholic hepatitis, Pharmacological therapies for ARLD, Nutritional therapy in alcoholic liver disease, Role of abstinence in disease reversal, Behavioral and addiction medicine approaches, Alcohol use disorder and liver health, Digital health tools for alcohol cessation, Multidisciplinary care models for ARLD, Liver transplantation in alcohol-related liver disease, Transplant eligibility and outcomes, Post-transplant management in ARLD patients, Alcohol-related hepatocellular carcinoma, Surveillance strategies in ARLD, Public health policies and alcohol control, Socioeconomic impact of alcohol-related liver disease, Gender differences in ARLD, Alcohol consumption patterns and risk stratification, Role of microbiome-based therapies, Emerging biologics and drug targets, Precision medicine in ARLD, Clinical trials in alcoholic liver disease, Regulatory challenges in ARLD drug development, Industry innovation in hepatology, Investment opportunities in liver disease therapies, Health economics of ARLD management, Patient-reported outcomes in ARLD, Quality of life in chronic liver disease, Preventive strategies for alcohol-related liver injury, Education and awareness initiatives, Global collaboration in ARLD research, Future directions in alcohol-related liver disease care
Keynote Points:
Rising adoption of diet-based management for chronic GI disorders
Strong market for medical foods, enteral nutrition, and specialized supplements
Growth of personalized nutrition and diet-planning platforms
Increasing role of dietitians and multidisciplinary GI care teams
Expansion into pediatric, geriatric, and oncology nutrition segments
Opportunities for clinical validation and science-backed product claims
Collaboration potential with gastroenterologists, hospitals, and wellness brands
Benefits:
Recurring revenue through long-term nutritional therapy and supplementation
High patient adherence and engagement with diet-based solutions
Strong brand credibility through clinical and dietary expertise
Cross-selling opportunities with diagnostics, therapeutics, and wellness products
Scalable business models via digital nutrition and subscription services
Alignment with preventive, patient-centric, and value-based healthcare
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com